MedTrace Logo

Risk Factors of Neonatal Thrombosis

NCT05367466 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2022-05-10

No results posted yet for this study

Summary

The incidence of symptomatic thrombosis is between 2.4 and 6.8 per 1000 neonatal intensive care unit admission while it is 5.1 per 100 000 live births. Compared to adults, the anticoagulant and fibrinolytic system of newborns is significantly different.

In this study, the aim is to evaluate infants with neonatal thrombosis in our unit to characterize acquired and genetic risk factors, the laboratory work-up parameters and the diagnosis approach.

Conditions

Sponsors & Collaborators

  • Kırıkkale University

    lead OTHER

Eligibility

Min Age
1 Day
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2019-12-30
Completion
2022-04-10

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05367466 on ClinicalTrials.gov